Metallic nanoparticles to eradicate bacterial bone infection

Shahnaz Qadri, Yousef Haik, Eric Mensah-Brown, Ghada Bashir, Maria J. Fernandez-Cabezudo, Basel K. al-Ramadi

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Treatment of osteomyelitis by conventional antibiotics has proven to be challenging due to limited accessibility to this unique location. Inorganic routes against bacterial infection have been reported for external and topical applications, however in vivo application of these antimicrobials has not been fully explored. Targeted delivery of metallic nanoparticles with inherent antimicrobial activity represents an alternative means of overcoming the challenges posed by multidrug-resistant bacteria and may potentially reduce overall morbidity. In this study we utilized silver–copper–boron composite nanoparticles in an attempt to eradicate S. aureus bone infection in mice. Our results demonstrate effective response when nanoparticles were administered via i.v. or i.m. route (1 mg/kg dose) where 99% of bacteria were eliminated in an induced osteomyelitis mouse model. The 1 mg/kg dose was neither toxic nor produced any adverse immune response, hence it is believed that metallic nanoparticles present an alternative to antibiotics for the treatment of bone infection.

Original languageEnglish
Pages (from-to)2241-2250
Number of pages10
JournalNanomedicine: Nanotechnology, Biology, and Medicine
Volume13
Issue number7
DOIs
Publication statusPublished - 1 Oct 2017
Externally publishedYes

Fingerprint

Metal Nanoparticles
Osteomyelitis
Bacterial Infections
Nanoparticles
Bone
Anti-Bacterial Agents
Bacteria
Bone and Bones
Poisons
Antibiotics
Infection
Morbidity
Composite materials

Keywords

  • Ag-Cu-B
  • Animal model
  • In vivo
  • Nanoparticles
  • Osteomyelitis

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Bioengineering
  • Biomedical Engineering
  • Molecular Medicine
  • Materials Science(all)
  • Pharmaceutical Science

Cite this

Qadri, S., Haik, Y., Mensah-Brown, E., Bashir, G., Fernandez-Cabezudo, M. J., & al-Ramadi, B. K. (2017). Metallic nanoparticles to eradicate bacterial bone infection. Nanomedicine: Nanotechnology, Biology, and Medicine, 13(7), 2241-2250. https://doi.org/10.1016/j.nano.2017.05.013

Metallic nanoparticles to eradicate bacterial bone infection. / Qadri, Shahnaz; Haik, Yousef; Mensah-Brown, Eric; Bashir, Ghada; Fernandez-Cabezudo, Maria J.; al-Ramadi, Basel K.

In: Nanomedicine: Nanotechnology, Biology, and Medicine, Vol. 13, No. 7, 01.10.2017, p. 2241-2250.

Research output: Contribution to journalArticle

Qadri, S, Haik, Y, Mensah-Brown, E, Bashir, G, Fernandez-Cabezudo, MJ & al-Ramadi, BK 2017, 'Metallic nanoparticles to eradicate bacterial bone infection', Nanomedicine: Nanotechnology, Biology, and Medicine, vol. 13, no. 7, pp. 2241-2250. https://doi.org/10.1016/j.nano.2017.05.013
Qadri, Shahnaz ; Haik, Yousef ; Mensah-Brown, Eric ; Bashir, Ghada ; Fernandez-Cabezudo, Maria J. ; al-Ramadi, Basel K. / Metallic nanoparticles to eradicate bacterial bone infection. In: Nanomedicine: Nanotechnology, Biology, and Medicine. 2017 ; Vol. 13, No. 7. pp. 2241-2250.
@article{58e3229188184f43a0c35ce22a990ed0,
title = "Metallic nanoparticles to eradicate bacterial bone infection",
abstract = "Treatment of osteomyelitis by conventional antibiotics has proven to be challenging due to limited accessibility to this unique location. Inorganic routes against bacterial infection have been reported for external and topical applications, however in vivo application of these antimicrobials has not been fully explored. Targeted delivery of metallic nanoparticles with inherent antimicrobial activity represents an alternative means of overcoming the challenges posed by multidrug-resistant bacteria and may potentially reduce overall morbidity. In this study we utilized silver–copper–boron composite nanoparticles in an attempt to eradicate S. aureus bone infection in mice. Our results demonstrate effective response when nanoparticles were administered via i.v. or i.m. route (1 mg/kg dose) where 99{\%} of bacteria were eliminated in an induced osteomyelitis mouse model. The 1 mg/kg dose was neither toxic nor produced any adverse immune response, hence it is believed that metallic nanoparticles present an alternative to antibiotics for the treatment of bone infection.",
keywords = "Ag-Cu-B, Animal model, In vivo, Nanoparticles, Osteomyelitis",
author = "Shahnaz Qadri and Yousef Haik and Eric Mensah-Brown and Ghada Bashir and Fernandez-Cabezudo, {Maria J.} and al-Ramadi, {Basel K.}",
year = "2017",
month = "10",
day = "1",
doi = "10.1016/j.nano.2017.05.013",
language = "English",
volume = "13",
pages = "2241--2250",
journal = "Nanomedicine: Nanotechnology, Biology, and Medicine",
issn = "1549-9634",
publisher = "Elsevier Inc.",
number = "7",

}

TY - JOUR

T1 - Metallic nanoparticles to eradicate bacterial bone infection

AU - Qadri, Shahnaz

AU - Haik, Yousef

AU - Mensah-Brown, Eric

AU - Bashir, Ghada

AU - Fernandez-Cabezudo, Maria J.

AU - al-Ramadi, Basel K.

PY - 2017/10/1

Y1 - 2017/10/1

N2 - Treatment of osteomyelitis by conventional antibiotics has proven to be challenging due to limited accessibility to this unique location. Inorganic routes against bacterial infection have been reported for external and topical applications, however in vivo application of these antimicrobials has not been fully explored. Targeted delivery of metallic nanoparticles with inherent antimicrobial activity represents an alternative means of overcoming the challenges posed by multidrug-resistant bacteria and may potentially reduce overall morbidity. In this study we utilized silver–copper–boron composite nanoparticles in an attempt to eradicate S. aureus bone infection in mice. Our results demonstrate effective response when nanoparticles were administered via i.v. or i.m. route (1 mg/kg dose) where 99% of bacteria were eliminated in an induced osteomyelitis mouse model. The 1 mg/kg dose was neither toxic nor produced any adverse immune response, hence it is believed that metallic nanoparticles present an alternative to antibiotics for the treatment of bone infection.

AB - Treatment of osteomyelitis by conventional antibiotics has proven to be challenging due to limited accessibility to this unique location. Inorganic routes against bacterial infection have been reported for external and topical applications, however in vivo application of these antimicrobials has not been fully explored. Targeted delivery of metallic nanoparticles with inherent antimicrobial activity represents an alternative means of overcoming the challenges posed by multidrug-resistant bacteria and may potentially reduce overall morbidity. In this study we utilized silver–copper–boron composite nanoparticles in an attempt to eradicate S. aureus bone infection in mice. Our results demonstrate effective response when nanoparticles were administered via i.v. or i.m. route (1 mg/kg dose) where 99% of bacteria were eliminated in an induced osteomyelitis mouse model. The 1 mg/kg dose was neither toxic nor produced any adverse immune response, hence it is believed that metallic nanoparticles present an alternative to antibiotics for the treatment of bone infection.

KW - Ag-Cu-B

KW - Animal model

KW - In vivo

KW - Nanoparticles

KW - Osteomyelitis

UR - http://www.scopus.com/inward/record.url?scp=85026371947&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85026371947&partnerID=8YFLogxK

U2 - 10.1016/j.nano.2017.05.013

DO - 10.1016/j.nano.2017.05.013

M3 - Article

VL - 13

SP - 2241

EP - 2250

JO - Nanomedicine: Nanotechnology, Biology, and Medicine

JF - Nanomedicine: Nanotechnology, Biology, and Medicine

SN - 1549-9634

IS - 7

ER -